statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time...

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific...

AbCellera Reports Q1 2024 Business Results

AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. We...

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

AbCellera (Nasdaq: ABCL), Viking Global Investors (Viking), and ArrowMark Partners (ArrowMark) announced today that they have entered into a collaboration to advance new antibody drug programs with...

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 at the San Diego Convention Center...

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the...

AbCellera Biologics (ABCL, $4.45) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that ABCL's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

AbCellera Biologics (ABCL, $4.53) Aroon Indicator entered a Downtrend on March 28, 2024.

AbCellera Biologics (ABCL, $4.5) Aroon Indicator entered a Downtrend on March 27, 2024.

AbCellera Biologics (ABCL, $4.5) RSI Indicator left the oversold zone on March 27, 2024

This is a signal that ABCL's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Volume	693,616.00
52-Wk High	$7.85
52-Wk Low	$2.65

ABCL AbCellera Biologics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals